Perioperative Care in Cardiac Surgery: A Joint Expert Consensus Document

All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.

Moderators

Daniel Engelman, MD
Disclosure(s): Alexion: Advisory Board (Ongoing); Arthrex: Advisory Board (Ongoing); Astellas Pharmaceuticals: Advisory Board (Ongoing); Edwards Life Science: Advisory Board (Ongoing); Medela: Advisory Board (Ongoing); Renibus Therapeutics: Advisory Board (Ongoing); Terumo: Advisory Board (Ongoing)

Moritz Wyler von Ballmoos, MD, PhD, MPH
Disclosure(s): Medtronic: Consultant (Ongoing); Boston Scientific Corporation: Consultant (Ongoing)

Presentations

  1. ERAS 2.0: What's New?
    Michael C. Grant, MD, MSE
     
  2. Preoperative Elements
    Rakesh C. Arora, MD, PhD, FRCSC
    Disclosure(s): Edwards LifeSciences: Speaker/Honoraria (Terminated, January 1, 2022); HLS Therapeutics Inc: Speaker/Honoraria (Terminated, September 21, 2022); Renibus Therapeutics Inc.: Advisory Board (Ongoing)
     
  3. Impact of High Intensity Statin on New-Onset Postoperative Atrial Fibrillation After Off-Pump Coronary Artery Bypass Graft Surgery
    Yeiwon Lee, MD
     
  4. Intraoperative Elements
    V. Seenu Reddy, MD MBA FACS
    Disclosure(s): Abiomed: Consultant (Ongoing)
     
  5. Prospective Trial of Oxygen Delivery on Cardiopulmonary Bypass and Major Clinical Outcomes
    Rawn Salenger, MD
    Disclosure(s): Atricure: Advisory Board (Ongoing); Edwards LifeSciences: Advisory Board (Terminated, November 1, 2022); Encare: Consultant (Ongoing); La Jolla: Advisory Board (Terminated, April 15, 2023); Society for the Advancement of Patient Blood Management: Co-lead of expert consensus project on surgical bleeding (Ongoing); Terumo: Consultant (Terminated, July 31, 2022); Zimmer Biomet: Advisory Board (Ongoing)
     
  6. Invited Discussant
    Glenn Whitman, MD
    Disclosure(s): Avania/Cellphire: Consultant (Ongoing); GWBN,LLC: Owner/Co-Owner Founder/Co-Founder (Ongoing)
     
  7. Postoperative Elements
    Cheryl Crisafi, MSN
     
  8. Experience with 1000 Consecutive Remotely Monitored Patients: The Scale and Spread of Success
    Kevin W. Lobdell, MD
    Disclosure(s): Abiomed: Consultant (Ongoing); Alexion: Consultant (Ongoing); Medela: Consultant (Ongoing); Medtronic: Consultant (Ongoing); Renibus Therapeutics: Consultant (Ongoing)
Activity summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Participation
Activity opens: 
02/01/2024
Activity expires: 
02/15/2027
Cost:
$0.00
Part of: 
2024 STS Annual Meeting Online: Critical Care and Perioperative Management Track
Rating: 
0

Available Credit

  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Participation

Price

Cost:
$0.00
Please login or register to take this course.

All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.

Moderators

Daniel Engelman, MD
Disclosure(s): Alexion: Advisory Board (Ongoing); Arthrex: Advisory Board (Ongoing); Astellas Pharmaceuticals: Advisory Board (Ongoing); Edwards Life Science: Advisory Board (Ongoing); Medela: Advisory Board (Ongoing); Renibus Therapeutics: Advisory Board (Ongoing); Terumo: Advisory Board (Ongoing)

Moritz Wyler von Ballmoos, MD, PhD, MPH
Disclosure(s): Medtronic: Consultant (Ongoing); Boston Scientific Corporation: Consultant (Ongoing)

Presentations

  1. ERAS 2.0: What's New?
    Michael C. Grant, MD, MSE
     
  2. Preoperative Elements
    Rakesh C. Arora, MD, PhD, FRCSC
    Disclosure(s): Edwards LifeSciences: Speaker/Honoraria (Terminated, January 1, 2022); HLS Therapeutics Inc: Speaker/Honoraria (Terminated, September 21, 2022); Renibus Therapeutics Inc.: Advisory Board (Ongoing)
     
  3. Impact of High Intensity Statin on New-Onset Postoperative Atrial Fibrillation After Off-Pump Coronary Artery Bypass Graft Surgery
    Yeiwon Lee, MD
     
  4. Intraoperative Elements
    V. Seenu Reddy, MD MBA FACS
    Disclosure(s): Abiomed: Consultant (Ongoing)
     
  5. Prospective Trial of Oxygen Delivery on Cardiopulmonary Bypass and Major Clinical Outcomes
    Rawn Salenger, MD
    Disclosure(s): Atricure: Advisory Board (Ongoing); Edwards LifeSciences: Advisory Board (Terminated, November 1, 2022); Encare: Consultant (Ongoing); La Jolla: Advisory Board (Terminated, April 15, 2023); Society for the Advancement of Patient Blood Management: Co-lead of expert consensus project on surgical bleeding (Ongoing); Terumo: Consultant (Terminated, July 31, 2022); Zimmer Biomet: Advisory Board (Ongoing)
     
  6. Invited Discussant
    Glenn Whitman, MD
    Disclosure(s): Avania/Cellphire: Consultant (Ongoing); GWBN,LLC: Owner/Co-Owner Founder/Co-Founder (Ongoing)
     
  7. Postoperative Elements
    Cheryl Crisafi, MSN
     
  8. Experience with 1000 Consecutive Remotely Monitored Patients: The Scale and Spread of Success
    Kevin W. Lobdell, MD
    Disclosure(s): Abiomed: Consultant (Ongoing); Alexion: Consultant (Ongoing); Medela: Consultant (Ongoing); Medtronic: Consultant (Ongoing); Renibus Therapeutics: Consultant (Ongoing)